AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
185.16
+2.99 (1.64%)
At close: Jul 26, 2024, 4:00 PM
184.69
-0.47 (-0.25%)
After-hours: Jul 26, 2024, 7:52 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $326.97 billion as of July 26, 2024. Its market cap has increased by 38.73% in one year.
Market Cap
326.97B
Enterprise Value
382.90B
1-Year Change
38.73%
Ranking
Category
Stock Price
$185.16
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $326.97B, an increase of 489.24%. That is a compound annual growth rate of 16.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 326.97B | 19.50% |
| Dec 29, 2023 | 273.61B | -4.27% |
| Dec 30, 2022 | 285.80B | 19.40% |
| Dec 31, 2021 | 239.37B | 26.54% |
| Dec 31, 2020 | 189.17B | 44.48% |
| Dec 31, 2019 | 130.93B | -5.58% |
| Dec 31, 2018 | 138.67B | -10.18% |
| Dec 29, 2017 | 154.39B | 51.71% |
| Dec 30, 2016 | 101.76B | 5.08% |
| Dec 31, 2015 | 96.84B | -7.12% |
| Dec 31, 2014 | 104.26B | 24.10% |
| Dec 31, 2013 | 84.01B | 51.40% |
| Jan 2, 2013 | 55.49B | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 780.46B |
| Novo Nordisk | 581.89B |
| UnitedHealth Group | 515.12B |
| Johnson & Johnson | 384.20B |
| Merck & Co. | 318.75B |
| AstraZeneca | 243.45B |
| Thermo Fisher | 226.93B |
| Novartis AG | 215.08B |